BioLife Solutions Inc (NASDAQ:BLFS) CFO Greef Roderick De sold 10,000 shares of BioLife Solutions stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $16.76, for a total value of $167,600.00. Following the completion of the sale, the chief financial officer now owns 40,359 shares in the company, valued at $676,416.84. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Greef Roderick De also recently made the following trade(s):
- On Wednesday, April 17th, Greef Roderick De sold 10,000 shares of BioLife Solutions stock. The shares were sold at an average price of $16.53, for a total value of $165,300.00.
- On Wednesday, March 20th, Greef Roderick De sold 10,000 shares of BioLife Solutions stock. The shares were sold at an average price of $19.83, for a total value of $198,300.00.
- On Wednesday, February 20th, Greef Roderick De sold 10,000 shares of BioLife Solutions stock. The shares were sold at an average price of $17.23, for a total value of $172,300.00.
BLFS stock opened at $18.22 on Monday. BioLife Solutions Inc has a 1-year low of $8.50 and a 1-year high of $26.35. The company has a debt-to-equity ratio of 0.02, a current ratio of 14.50 and a quick ratio of 12.99. The firm has a market capitalization of $342.52 million, a PE ratio of 130.14 and a beta of 1.53.
A number of research analysts have issued reports on BLFS shares. ValuEngine upgraded BioLife Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, January 31st. BidaskClub upgraded BioLife Solutions from a “hold” rating to a “buy” rating in a research note on Friday, March 1st. Finally, Zacks Investment Research cut BioLife Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday, March 12th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $18.20.
Several hedge funds have recently bought and sold shares of BLFS. Cowen Prime Services LLC purchased a new stake in BioLife Solutions during the first quarter valued at $63,000. Canton Hathaway LLC bought a new position in shares of BioLife Solutions in the fourth quarter worth about $66,000. Ladenburg Thalmann Financial Services Inc. boosted its stake in shares of BioLife Solutions by 281.3% in the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 5,380 shares of the medical equipment provider’s stock worth $96,000 after acquiring an additional 3,969 shares during the period. Signaturefd LLC bought a new position in shares of BioLife Solutions in the first quarter worth about $161,000. Finally, GSA Capital Partners LLP boosted its stake in shares of BioLife Solutions by 21.1% in the fourth quarter. GSA Capital Partners LLP now owns 13,800 shares of the medical equipment provider’s stock worth $166,000 after acquiring an additional 2,400 shares during the period. Hedge funds and other institutional investors own 41.21% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Greef Roderick De Sells 10,000 Shares of BioLife Solutions Inc (BLFS) Stock” was originally reported by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/20/greef-roderick-de-sells-10000-shares-of-biolife-solutions-inc-blfs-stock.html.
About BioLife Solutions
BioLife Solutions, Inc develops, manufactures, and markets grade cell and tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced cell damage and death.
Featured Story: What is Considered a Good Return on Equity (ROE)?
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.